| dc.contributor.advisor | HIDAYATI, TITIEK | |
| dc.contributor.author | RAHMAWATI, RIKA ESTRI | |
| dc.date.accessioned | 2019-06-27T06:35:20Z | |
| dc.date.available | 2019-06-27T06:35:20Z | |
| dc.date.issued | 2019-01-11 | |
| dc.identifier.uri | http://repository.umy.ac.id/handle/123456789/27546 | |
| dc.description | Sejak tahun 1995, upaya pengendalian tuberkulosis (TB) dengan strategi DOTS telah
diterapkan di banyak negara. Namun sampai saat ini masih merupakan salah satu masalah
kesehatan masyarakat di dunia. Upaya paling efisien untuk mencegah penyebaran lebih
lanjut dari kuman tuberkulosis (TB) adalah dilakukannya pengobatan tuberkulosis (TB).
Agar pengobatan tuberkuosis (TB) tersebut adekuat, salah satunya harus diawasi secara
langsung oleh Pendamping Minum Obat (PMO) hingga selesai pengobatan. Tujuan
penelitian ini adalah untuk mengetahui faktor jenis dan peran pendamping minum obat
terhadap keberhasilan terapi tuberkulosis. Metode penelitian Kohort Prospektif. Penelitian
dilakukan selama 6 bulan dengan total 57 pasien tuberkulosis. Pengumpulan data primer
dilakukan dengan wawancara menggunakan kuesioner yang telah tervalidasi. Pengambilan
data sekunder dilakukan untuk memperoleh data terapeutik, hasil klinis, laboratorium dan
radiologi. Hasil penelitian menunjukkan jenis pendamping minum obat tidak memiliki
hubungan yang bermakna terhadap keberhasilan terapi, pendamping minum obat yang
memiliki peran baik berisiko 6 kali untuk dapat mengalami keberhasilan terapi dan
bermakna secara statistik (p=0,011). | en_US |
| dc.description.abstract | Since 1995, efforts to control tuberculosis (TB) with the DOTS strategy have been applied
in many countries. But until now it is still one of the public health problems in the world.
The most efficient effort to prevent further spread of tuberculosis (TB) germs is to treat
tuberculosis (TB). In order for the tuberculosis (TB) treatment to be adequate, one of them
must be monitored directly by the Companion to Take Medication until completion of
treatment. The purpose of this study was to determine the type of factor and the role of
companion in taking medication for the success of tuberculosis therapy. Prospective
Cohort research method. The study was conducted for 6 months with a total of 57
tuberculosis patients. Primary data collection was done by interviewing using a validated
questionnaire. Secondary data collection was done to obtain therapeutic data, clinical,
laboratory and radiological results. The results showed that the type of companion taking
medication did not have a significant relationship to the success of the therapy, the
companion took medicine that had a good role at risk of 6 times to be able to experience
therapeutic success and statistically significant (p = 0.011). | en_US |
| dc.publisher | FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS MUHAMMADIYAH YOGYAKARTA | en_US |
| dc.subject | Success of therapy, companion taking medication, tuberculosis | en_US |
| dc.title | FAKTOR JENIS DAN PERAN PENDAMPING MINUM OBAT (PMO) TERHADAP KEBERHASILAN TERAPI TUBERKULOSIS (TB) | en_US |
| dc.type | Thesis
SKR
FKIK
057 | en_US |
